These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12191852)

  • 1. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial.
    Chiechi LM; Secreto G; D'Amore M; Fanelli M; Venturelli E; Cantatore F; Valerio T; Laselva G; Loizzi P
    Maturitas; 2002 Aug; 42(4):295-300. PubMed ID: 12191852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency.
    Arjmandi BH
    J Am Coll Nutr; 2001 Oct; 20(5 Suppl):398S-402S; discussion 417S-420S. PubMed ID: 11603649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: a randomized controlled trial.
    Lambert MNT; Thybo CB; Lykkeboe S; Rasmussen LM; Frette X; Christensen LP; Jeppesen PB
    Am J Clin Nutr; 2017 Sep; 106(3):909-920. PubMed ID: 28768651
    [No Abstract]   [Full Text] [Related]  

  • 4. Soy isoflavones: hope or hype?
    Fitzpatrick LA
    Maturitas; 2003 Mar; 44 Suppl 1():S21-9. PubMed ID: 12609556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Piaggesi L; Genazzani AR
    Maturitas; 1997 Sep; 28(1):75-81. PubMed ID: 9391998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial.
    Levis S; Strickman-Stein N; Ganjei-Azar P; Xu P; Doerge DR; Krischer J
    Arch Intern Med; 2011 Aug; 171(15):1363-9. PubMed ID: 21824950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy isoflavones for osteoporosis: an evidence-based approach.
    Taku K; Melby MK; Nishi N; Omori T; Kurzer MS
    Maturitas; 2011 Dec; 70(4):333-8. PubMed ID: 21958941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis.
    Eviö S; Tiitinen A; Laitinen K; Ylikorkala O; Välimäki MJ
    J Clin Endocrinol Metab; 2004 Feb; 89(2):626-31. PubMed ID: 14764773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytoestrogens.
    Cabot W
    J Am Acad Orthop Surg; 2003; 11(3):153-6. PubMed ID: 12828444
    [No Abstract]   [Full Text] [Related]  

  • 10. Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys.
    Register TC; Jayo MJ; Anthony MS
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4362-70. PubMed ID: 12970311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial.
    Roudsari AH; Tahbaz F; Hossein-Nezhad A; Arjmandi B; Larijani B; Kimiagar SM
    Nutr J; 2005 Oct; 4():30. PubMed ID: 16255781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.
    Gutteridge DH; Holzherr ML; Retallack RW; Price RI; Will RK; Dhaliwal SS; Faulkner DL; Stewart GO; Stuckey BG; Prince RL; Criddle RA; Drury PJ; Tran L; Bhagat CI; Kent GN; Jamrozik K
    Calcif Tissue Int; 2003 Jul; 73(1):33-43. PubMed ID: 14506952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary phytoestrogens in the prevention of long-term postmenopausal diseases.
    Chiechi LM
    Int J Gynaecol Obstet; 1999 Oct; 67(1):39-40. PubMed ID: 10576238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
    Bhattoa HP; Bettembuk P; Balogh A; Szegedi G; Kiss E
    Osteoporos Int; 2004 May; 15(5):396-404. PubMed ID: 14676992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.
    Milliken LA; Going SB; Houtkooper LB; Flint-Wagner HG; Figueroa A; Metcalfe LL; Blew RM; Sharp SC; Lohman TG
    Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
    J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy isoflavones for prevention of menopausal bone loss and vasomotor symptoms: comment on "Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms".
    Newton KM; Grady D
    Arch Intern Med; 2011 Aug; 171(15):1369-70. PubMed ID: 21824951
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of postmenopausal osteoporosis with oestrogen replacement therapy and associated compounds: update on clinical trials since 1995.
    Dören M; Samsioe G
    Hum Reprod Update; 2000; 6(5):419-26. PubMed ID: 11045872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause.
    Woo J; Lau E; Ho SC; Cheng F; Chan C; Chan AS; Haines CJ; Chan TY; Li M; Sham A
    Menopause; 2003; 10(4):352-61. PubMed ID: 12851519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C; Dane B; Cetin A; Erginbas M
    Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.